Publications by authors named "Timothy Beard"

Claim this Profile
A
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP.
J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Timothy Beard

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma.
J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Rohit Sharma, Timothy Beard

World J Surg Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study.
Maki Yamamoto, Brenda Sickle-Santanello, Timothy Beard, Richard Essner, Brian Martin

Curr Med Res Opin· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Timothy L Beard, Cathy Michalsky, Keith A Candiotti, Paul Rider, Linda Wase

Pain Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.
Sergio D Bergese, Marek Brzezinski, Gregory B Hammer, Timothy L Beard, Peter H Pan

J Pain Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
Cheryl T Lee, Sam S Chang, Ashish M Kamat, Gilad Amiel, Timothy L Beard

Eur Urol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
Teresa L Kauf, Robert S Svatek, Gilad Amiel, Timothy L Beard, Sam S Chang

J Urol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The opioid component of delayed gastrointestinal recovery after bowel resection.
Timothy L Beard, John B Leslie, Jeffrey Nemeth

J Gastrointest Surg· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of surgical care practices with length of stay and use of clinical protocols after elective bowel resection: results of a national survey.
Conor P Delaney, Anthony J Senagore, Todd M Gerkin, Timothy L Beard, Wendy M Zingaro

Am J Surg· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deracemisation and stereoinversion of alpha-amino acids using D-amino acid oxidase and hydride reducing agents.
Timothy M Beard, Nicholas J Turner

Chem Commun (Camb)· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis